These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 1535454)
1. Depo-Provera. Controversial contraceptive wins approval from FDA panel. Stone R Science; 1992 Jun; 256(5065):1754. PubMed ID: 1535454 [No Abstract] [Full Text] [Related]
2. Depo-Provera: a critical analysis. Minkin S Women Health; 1980; 5(2):49-69. PubMed ID: 6451987 [TBL] [Abstract][Full Text] [Related]
3. Drug regulation in the United States and the United Kingdom: the Depo-Provera story. Richard BW; Lasagna L Ann Intern Med; 1987 Jun; 106(6):886-91. PubMed ID: 2953290 [TBL] [Abstract][Full Text] [Related]
5. The Food and Drug Administration and medroxyprogesterone acetate. What are the issues? Rosenfield A; Maine D; Rochat R; Shelton J; Hatcher RA JAMA; 1983 Jun; 249(21):2922-8. PubMed ID: 6221125 [TBL] [Abstract][Full Text] [Related]
6. A case for concern? Gartland A Nurs Times; 1983 May 4-10; 79(18):10-1. PubMed ID: 6222288 [TBL] [Abstract][Full Text] [Related]
7. Update on Depo-Provera. Sapire KE S Afr Med J; 1992 May; 81(9):444-5. PubMed ID: 1533472 [No Abstract] [Full Text] [Related]
8. Depo-provera in the First World. McDonough RT Hastings Cent Rep; 1988; 18(4):44-5. PubMed ID: 2975641 [No Abstract] [Full Text] [Related]
10. Medroxyprogesterone (Depo Provera) and breast cancer. McCowan L N Z Med J; 1990 May; 103(889):225-6. PubMed ID: 2140436 [No Abstract] [Full Text] [Related]
11. Depo Provera and breast cancer. McCowan L; Farquhar C; Roke C; Liddell H; Roberts H; Thakurdas N; Wilson J; Say PJ; McClure F N Z Med J; 1991 Jan; 104(904):16-7. PubMed ID: 1826144 [No Abstract] [Full Text] [Related]
12. Depo-Provera debate revs up at FDA. Sun M Science; 1982 Jul; 217(4558):424-8. PubMed ID: 6211767 [No Abstract] [Full Text] [Related]
13. [Depo-Provera--antineoplastic agents which is also a contraceptive]. Tylleskär J Jordemodern; 1988 Mar; 101(3):55-8. PubMed ID: 2967271 [No Abstract] [Full Text] [Related]
15. Depo-Provera--ethical issues in its testing and distribution. Potts M; Paxman JM J Med Ethics; 1984 Mar; 10(1):9-20. PubMed ID: 6231379 [TBL] [Abstract][Full Text] [Related]
16. Not FDA-approved, but experts recommend Depo-Provera. Contracept Technol Update; 1992 Jan; 13(1):1-7. PubMed ID: 12343458 [TBL] [Abstract][Full Text] [Related]
17. The FDA, contraceptive marketing approval and products liability litigation: Depo-Provera and the risk of osteoporosis. Green W Food Drug Law J; 2013; 68(2):115-35, i. PubMed ID: 24640465 [TBL] [Abstract][Full Text] [Related]
18. Depo-provera. A lesson in communication. Dennerstein G Aust Fam Physician; 1988 Mar; 17(3):176-8. PubMed ID: 2965569 [No Abstract] [Full Text] [Related]
20. The Women's Health and Reproductive Rights Campaign on depo provera. More than just a little prick. Health Visit; 1989 Jul; 62(7):228. PubMed ID: 2526797 [No Abstract] [Full Text] [Related] [Next] [New Search]